The study was a single-center, open-label trial. Treatment consisted of 6 weekly subcutaneous injections (sc) of pentosan (2mg/kg). Patients were clinically assessed at entry and 1 to 8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback